loadpatents
name:-0.084207057952881
name:-0.033797025680542
name:-0.0060439109802246
Ostman; Arne Patent Filings

Ostman; Arne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ostman; Arne.The latest application filed is for "identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib".

Company Profile
0.5.9
  • Ostman; Arne - Uppsala SE
  • Ostman; Arne - Stockholm SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination comprising a signal transduction inhibitor and an epothilone derivative
Grant 7,723,339 - Brandt , et al. May 25, 2
2010-05-25
Identification And Characterization Of A Subset of Glioblastomas Sensitive To Treatment With Imatinib
App 20080199855 - Nister; Monica ;   et al.
2008-08-21
Density enhanced protein tyrosine phosphatases
App 20070190581 - Tonks; Nicholas K. ;   et al.
2007-08-16
Density enhanced protein tyrosine phosphatases
Grant 7,195,762 - Tonks , et al. March 27, 2
2007-03-27
Enhancing the effect of radioimmunotherapy in the treatment of tumors
App 20070037825 - Baranowska-Kortylewicz; Janina ;   et al.
2007-02-15
Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
App 20070021327 - Pietras; Kristian ;   et al.
2007-01-25
Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
Grant 7,141,375 - Pietras , et al. November 28, 2
2006-11-28
Combination for the treatment of endothelial damage
Grant 6,974,816 - Alitalo , et al. December 13, 2
2005-12-13
Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
App 20040224335 - Pietras, Kristian ;   et al.
2004-11-11
Combination comprising a signal transduction inhibitor and an epothilone derivative
App 20040132754 - Brandt, Ralf ;   et al.
2004-07-08
Method for treatment of tumors using nucleic acid ligands to PDGF
Grant 6,699,843 - Pietras , et al. March 2, 2
2004-03-02
Density enhanced protein tyrosine phosphatases
App 20030148491 - Tonks, Nicholas K. ;   et al.
2003-08-07
Combination for the treatment of endothelial damage
App 20030099687 - Alitalo, Kari ;   et al.
2003-05-29
Method for treatment of tumors using nucleic acid ligands to PDGF
App 20020034506 - Pietras, Kristian ;   et al.
2002-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed